Waldenström macroglobulinemia (WM) is an uncommon lymphoma characterized by the
infiltration of the bone marrow by clonal lymphoplasmacytic cells that produce monoclonal …

After 77 years since the initial description, Waldenström macroglobulinemia (WM) remains
as a bone marrow neoplastic disorder with lymphoplasmacytic differentiation oversecreting …

The current therapeutic approach in Waldenström's macroglobulinemia (WM) is being driven
by insights in disease biology and genomic landscape. Bruton's tyrosine kinase (BTK) plays …

Waldenström macroglobulinemia (WM) is a rare, indolent lymphoma, that predominately
affects the elderly. We report the outcomes of young WM patients, evaluated over five …

The immunoglobulin M (IgM)-associated peripheral neuropathies (PNs) are a
heterogeneous group of disorders that can result in significant disability, and together they …

Clinical features in patients with the B-cell lymphoma, Waldenström macroglobulinemia
(WM), include cytopenias, immunoglobulin M (IgM)–mediated hyperviscosity, fatigue …

We present a nationwide prospective Swedish registry‐based study of Waldenström
macroglobulinaemia (WM), that focuses on incidence and survival in relation to clinical …

Abstract Purpose of Review The treatment of Waldenström macroglobulinemia (WM) has
evolved over the past decade. With the seminal discoveries of MYD 88 and CXCR warts …

Waldenström macroglobulinemia is a rare hematologic malignancy characterized by an IgM-
associated lymphoplasmacytic lymphoma. Often, it is associated with an indolent disease …

We analyzed 160 young Waldenström Macroglobulinemia (WM) patients with a median age
of 49 years (range 23‐55 years), diagnosed between January 2000 and January 2019 in 14 …